Mycophenolate mofetil versus placebo for systemic sclerosis–related interstitial lung disease: an analysis of scleroderma lung studies I and II

ER Volkmann, DP Tashkin, N Li, MD Roth… - Arthritis & …, 2017 - Wiley Online Library
Objective To compare mycophenolate mofetil (MMF) with placebo for the treatment of
systemic sclerosis (SSc)–related interstitial lung disease (ILD). Methods We included …
被引用次数：158 相关文章

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.

ER Volkmann, DP Tashkin, N Li, MD Roth… - Arthritis & …, 2017 - europepmc.org
Objective To compare mycophenolate mofetil (MMF) with placebo for the treatment of
systemic sclerosis (SSc)-related interstitial lung disease (ILD). Methods We included …

[引用][C] Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

ER Volkmann, DP Tashkin, N Li, MD Roth… - Arthritis & …, 2017 - cir.nii.ac.jp
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung
Disease: An Analysis of Scleroderma Lung Studies I and II | CiNii Research CiNii 国立情報学 …
[HTML] nih.gov

[HTML][HTML] Mycophenolate versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

ER Volkmann, DP Tashkin, N Li, MD Roth… - Arthritis & …, 2017 - ncbi.nlm.nih.gov
Objective To compare mycophenolate (MMF) with placebo for the treatment of systemic
sclerosis-related interstitial lung disease (SSc-ILD). Methods Participants enrolled in the …

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

ER Volkmann, DP Tashkin, N Li, MD Roth… - Arthritis & …, 2017 - escholarship.org
ObjectiveTo compare mycophenolate mofetil (MMF) with placebo for the treatment of
systemic sclerosis (SSc)-related interstitial lung disease (ILD). MethodsWe included …

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.

ER Volkmann, DP Tashkin, N Li… - Arthritis & …, 2017 - search.ebscohost.com
Objective To compare mycophenolate mofetil (MMF) with placebo for the treatment of
systemic sclerosis (SSc)-related interstitial lung disease (ILD). Methods We included …

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

ER Volkmann, DP Tashkin, N Li… - Arthritis & …, 2017 - pubmed.ncbi.nlm.nih.gov
Objective To compare mycophenolate mofetil (MMF) with placebo for the treatment of
systemic sclerosis (SSc)-related interstitial lung disease (ILD). Methods We included …

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.

ER Volkmann, DP Tashkin, N Li, MD Roth… - Arthritis & …, 2017 - europepmc.org
Objective To compare mycophenolate mofetil (MMF) with placebo for the treatment of
systemic sclerosis (SSc)-related interstitial lung disease (ILD). Methods We included …